Tax-saving equity-linked savings schemes saw month-on-month rise in inflows at Rs 1,166 crores.
Indian companies have made acquisitions of $1 billion so far in January
Real estate will prosper, small developers won't.
In the 52 newly listed companies since 2014, fund managers have a total investment of a mere 2.5 per cent of their assets under management.
Industry body Amfi to hold meeting to decide on road map.
The National Stock Exchange's proposed IPO to raise Rs 10,000 crore this year is expected to see the largest ever PE exit, of around Rs 5,000 crore.
Experts say investors should stay patient and stay invested in mutual funds.
Cross previous high of $72 billion in 2007 as Indian promoters overcome the selling taboo. Abhineet Kumar reports from Mumbai.
At the start of 2016, HDFC Bank, Infosys, ICICI Bank, L&T and Axis Bank were the top five picks of fund managers
The average fall in 15 most-invested stocks by equity MFs was 5.7 per cent. Chandan Kishore Kant reports
Underweight on the sector since January amid concerns over growth prospects; no early reversal seen
Accumulated sum Rs 31,500 crore in 2015-16
Most equity schemes have more than doubled their NAVs in 8 years, even if they entered at the pre-Lehman crisis peak
The venture is applying to the Reserve Bank of India for approvals.
Worst performers among category funds, but beat sectoral indices
Corrective measures are already being taken by fund managers - overall allocation to the IT firm has been pruned by 120 basis points, from 4.43 per cent in March to 3.24 per cent in July
The Aditya Birla Group announced the merger of its two holding companies, Aditya Birla Nuvo and Grasim, to make the holding structure clearer, ensure stable cash flows and unlock value in its financial services arm
Sixteen companies in the group registered a turnover of over $500 million, with ten of these registering a turnover of over $1 billion
The founders of Gland Pharma, led by Ravi Penmetsa, and KKR, together own 96 per cent of the company.
© 2025 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances